HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aetiology and outcome of elderly burn patients in tabriz, iran.

Abstract
Background. Geriatric patients, usually defined as being 65 years of age or over, now make up about 10% of the major burn population. Main aim. To conduct a prospective study of elderly burn patients, analysing the predictive value of age, gender, total body surface area (TBSA) burned, inhalation trauma, pre-morbid conditions, and mortality. Methods. A 10-year prospective study of burn victims hospitalized in a major burn centre in Iran was conducted to analyse the association between age, percentage TBSA burn, inhalation injury, the causes of the burns, pre-existing co-morbid conditions and the risk of death, and the epidemiology of the burns. Results. Three hundred and eighty patients aged 65 years and over were identified. The mean patient age was 71 years. There were 109 deaths overall (28.7%), the majority of which (74) were among patients with self-inflicted burns. Except for the incidence of the burns, there were no significant differences between males and females. The mean burn size (21.6%) was significantly larger in non-survivors than in survivors (49.5% vs 10.3%; p < 0.001). In these 380 elderly burn patients, when the TBSA burned exceeded 50% mortality reached 100%. Inhalation injuries were strongly associated with large burns and were present in the majority of flame-burn fatalities. There were no deaths related to scalds. Pre-morbid conditions had no statistically significant influence on mortality. Conclusion. Large burn size was the strongest predictor of mortality among elderly burn patients, followed by the presence of inhalation injury. This study showed that burn patients aged 65 years and over can achieve a good outcome.
AuthorsH Maghsoudi, A Ghaffari
JournalAnnals of burns and fire disasters (Ann Burns Fire Disasters) Vol. 22 Issue 3 Pg. 115-20 (Sep 30 2009) ISSN: 1592-9558 [Print] Italy
PMID21991165 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: